Page last updated: 2024-08-24

topotecan and Labhart-Willi Syndrome

topotecan has been researched along with Labhart-Willi Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ach, RA; Adams, S; Chédin, F; Coulson, RL; Crary, FK; Gonzales, ML; LaSalle, JM; Powell, WT; Tsang, P; Wong, SS; Yamada, NA; Yasui, DH1

Other Studies

1 other study(ies) available for topotecan and Labhart-Willi Syndrome

ArticleYear
R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Aug-20, Volume: 110, Issue:34

    Topics: Angelman Syndrome; Animals; Chromatin; Chromatin Immunoprecipitation; Chromosomes, Human, Pair 15; Gene Expression Regulation; Gene Silencing; Genetic Loci; Genomic Imprinting; HEK293 Cells; Humans; Immunoblotting; In Situ Hybridization, Fluorescence; Locus Control Region; Mice; Mice, Knockout; Neurons; Prader-Willi Syndrome; Real-Time Polymerase Chain Reaction; RNA, Antisense; RNA, Small Nucleolar; snRNP Core Proteins; Statistics, Nonparametric; Topotecan; Ubiquitin-Protein Ligases

2013